The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies
Open accessAbstract
Chronic kidney disease (CKD) is a long-term condition in which the kidneys do not work correctly. It has a high prevalence and represents a serious hazard to human health and estimated to affects hundreds of millions of people. Diabetes and hypertension are the two principal causes of CKD. The progression of CKD is characterized by the loss of renal cells and their replacement by extracellular matrix (ECM), independently of the associated disease. Thus, one of the consequences of CKD is glomerulosclerosis and tubulointerstitial fibrosis caused by an imbalance between excessive synthesis and reduced breakdown of the ECM. There are many molecules and cells that are associated with progression of renal fibrosis e.g. angiotensin II (Ang II). Therefore, in order to understand the biopathology of renal fibrosis and for the evaluation of new treatments, the use of animal models is crucial such as: surgical, chemical and physical models, spontaneous models, genetic models and in vitro models. However, there are currently no effective treatments for preventing the progression of renal fibrosis. Therefore it is essential to improve our knowledge of the cellular and molecular mechanisms of the progress of renal fibrosis in order to achieve a reversion/elimination of renal fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
Miller, E. R., Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-1-200501040-00110 · Cited by 2,577
Non-Transgenic Mouse Models of Kidney Disease
Rabe, M., & Schaefer, F. (2016) · Nephron · doi:10.1159/000445171 · Cited by 1,922
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation
Hostetter, T. H., Olson, J. L., Rennke, H. G., Venkatachalam, M. A., & Brenner, B. M. (1981) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1981.241.1.f85 · Cited by 1,680
Cellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis
Humphreys, B. D., Lin, S.-L., Kobayashi, A., Hudson, T. E., Nowlin, B. T., Bonventre, J. V., Valerius, M. T., McMahon, A. P., & Duffield, J. S. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090517 · Cited by 1,442
Kagami, S., Border, W. A., Miller, D. E., & Noble, N. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117251 · Cited by 1,076
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy
Chevalier, R. L., Forbes, M. S., & Thornhill, B. A. (2009) · Kidney International · doi:10.1038/ki.2009.86 · Cited by 1,029
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
Nath, K. A. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80312-x · Cited by 974
New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
Liu, Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121226 · Cited by 870
Lin, S.-L., Kisseleva, T., Brenner, D. A., & Duffield, J. S. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080433 · Cited by 845
Projecting the Number of Patients with End-Stage Renal Disease in the United States to the Year 2015
Gilbertson, D. T., Liu, J., Xue, J. L., Louis, T. A., Solid, C. A., Ebben, J. P., & Collins, A. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010112 · Cited by 719
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
Remuzzi, G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27699 · Cited by 618
Maintenance Dialysis Population Dynamics: Current Trends and Long-Term Implications
Lysaght, M. J. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v13suppl_1s37 · Cited by 609
Branton, M. H., & Kopp, J. B. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00250-6 · Cited by 603
Obstructive nephropathy and renal fibrosis
Klahr, S., & Morrissey, J. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00362.2001 · Cited by 555
Lee, K. S., Buck, M., Houglum, K., & Chojkier, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118304 · Cited by 539
A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats.
Shimamura, T., & Morrison, A. B. (1975) · PubMed · Cited by 449
Interactions of Transforming Growth Factor-β and Angiotensin II in Renal Fibrosis
Border, W. A., & Noble, N. A. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.181 · Cited by 447
Angiotensin II Type 1a Receptor-deficient Mice with Hypotension and Hyperreninemia
Sugaya, T., Nishimatsu, S.-I., Tanimoto, K., Takimoto, E., Yamagishi, T., Imamura, K., Goto, S., Imaizumi, K., Hisada, Y., Otsuka, A., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.32.18719 · Cited by 366
Xue, J. L., Ma, J. Z., Louis, T. A., & Collins, A. J. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12122753 · Cited by 348
Fibroblasts and myofibroblasts in renal fibrosis
Meran, S., & Steadman, R. (2011) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2011.00764.x · Cited by 346
Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events
Wang, Y., Wang, Y. P., Tay, Y.-C., & Harris, D. C. H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00342.x · Cited by 326
Models of chronic kidney disease
Yang, H.-C., Zuo, Y., & Fogo, A. B. (2010) · Drug Discovery Today: Disease Models · doi:10.1016/j.ddmod.2010.08.002 · Cited by 291
Gupta, S., Clarkson, M. R., Duggan, J., & Brady, H. R. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00301.x · Cited by 283
HIV-associated nephropathy in transgenic mice expressing HIV-1 genes
Dickie, P., Felser, J., Eckhaus, M., Bryant, J., Silver, J., Marinos, N., & Notkins, A. L. (1991) · Virology · doi:10.1016/0042-6822(91)90759-5 · Cited by 282
Yang, F., Chung, A. C. K., Huang, X. R., & Lan, H. Y. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.136531 · Cited by 258
Model of robust induction of glomerulosclerosis in mice: Importance of genetic background
Ma, L.-J., & Fogo, A. B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00058.x · Cited by 246
Renal tubulointerstitial fibrosis: common but never simple
Hewitson, T. D. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90521.2008 · Cited by 246
Matsusaka, T., Xin, J., Niwa, S., Kobayashi, K., Akatsuka, A., Hashizume, H., Wang, Q.-C., Pastan, I., Fogo, A. B., & Ichikawa, I. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080720 · Cited by 242
Functional correlates of compensatory renal hypertrophy
Hayslett, J. P., Kashgarian, M., & Epstein, F. H. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105772 · Cited by 213
Long-term outcome in children and adults with classic focal segmental glomerulosclerosis
Cattran, D., & Rao, P. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9669427 · Cited by 212
Miric, G., Dallemagne, C., Endre, Z., Margolin, S., Taylor, S. M., & Brown, L. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704131 · Cited by 210
The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease
Klahr, S., & Morrissey, J. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07509.x · Cited by 194
Common pathophysiological mechanisms of chronic kidney disease: Therapeutic perspectives
López-Novoa, J. M., Martínez-Salgado, C., Rodríguez-Peña, A. B., & Hernández, F. J. L. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.05.006 · Cited by 189
Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy
Grande, M. T., Pérez‐Barriocanal, F., & López-Novoa, J. M. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-19 · Cited by 182
(2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261315 · Cited by 180
Phanish, M. K., Winn, S. K., & Dockrell, M. E. C. (2009) · Nephron Experimental Nephrology · doi:10.1159/000262316 · Cited by 179
Renal epithelial injury and fibrosis
Kaissling, B., LeHir, M., & Kriz, W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.02.010 · Cited by 167
Treatment targets in renal fibrosis
Boor, P., Šebeková, K., Ostendorf, T., & Floege, J. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm393 · Cited by 164
Pirfenidone improves renal function and fibrosis in the post-obstructed kidney
Shimizu, T., Kuroda, T., Hata, S., Fukagawa, M., Margolin, S. B., & Kurokawa, K. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00962.x · Cited by 161
Hartner, A., Cordasic, N., Klanke, B., Veelken, R., & Hilgers, K. F. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg299 · Cited by 161
Angiotensin in progressive renal diseases
Matsusaka, T., Hymes, J. L., & Ichikawa, I. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v7102025 · Cited by 157
Yuan, H., Li, X.-Z., Pitera, J. E., Long, D. A., & Woolf, A. S. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63586-9 · Cited by 150
Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease
Groß, O., Girgert, R., Beirowski, B., Kretzler, M., Kang, H. G., Kruegel, J., Miosge, N., Busse, A. C., Segerer, S., Vogel, W. F., et al. (2010) · Matrix Biology · doi:10.1016/j.matbio.2010.03.002 · Cited by 140
Progression and potential regression of glomerulosclerosis
Fogo, A. B. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002804.x · Cited by 135
Benfield, M. R., McDonald, R. A., Bartosh, S. M., Ho, M., & Harmon, W. (2003) · Pediatric Transplantation · doi:10.1034/j.1399-3046.2003.00029.x · Cited by 131
Shin, D., Park, H.-M., Jung, K.-A., Choi, H.-G., Kim, J., Kim, D., Kim, S. G., Kang, K. W., Ku, S., Kensler, T. W., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.01.021 · Cited by 114
Functional and Structural Correlates of Glomerulosclerosis after Renal Mass Reduction in the Rat
Griffin, K. A., Picken, M. M., Churchill, M. C., Churchill, P. C., & BIDANI, A. K. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v113497 · Cited by 111
Takada, M., Nadeau, K. C., Shaw, G. D., & Tilney, N. L. (1997) · Transplantation · doi:10.1097/00007890-199712150-00003 · Cited by 107
Ucero, A. C., Benito‐Martín, A., Calvo, I. F., Santamaría, B., Blanco, J., López-Novoa, J. M., Ruiz‐Ortega, M., Egido, J., Burkly, L. C., Martínez‐Salgado, C., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.032 · Cited by 101
Blood Pressure, Cardiac, and Renal Responses to Salt and Deoxycorticosterone Acetate in Mice
Wang, Q., Hümmler, E., Nussberger, J., Clément, S., Gabbiani, G., Brunner, H. R., & Burnier, M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000017902.77985.84 · Cited by 78
Role of anti-TGF-β antibodies in the treatment of renal injury
Gagliardini, E., & Benigni, A. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.005 · Cited by 75
Klein, J., Gonzalez, J., Duchêne, J., Esposito, L., Pradère, J., Neau, E., Delage, C., Calise, D., Ahluwalia, A., Carayon, P., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-115600 · Cited by 74
da Silveira, K. D., Barroso, L. C., Vieira, A. T., Cisalpino, D., Lima, C. X., Bäder, M., Arantes, R. M. E., Santos, R. A. S., Silva, A. C. S. E., & Teixeira, M. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066082 · Cited by 72
Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosis
Tan, X., Li, Y., & Liu, Y. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.11.011 · Cited by 72
Fleck, C., Appenroth, D., Jonas, P., Koch, M., Kundt, G., Nizze, H., & Stein, G. (2005) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2005.09.005 · Cited by 69
Rodrigues-Díez, R. R., Rodrigues‐Díez, R., Lavoz, C., Rayego‐Mateos, S., Civantos, E., Rodríguez‐Vita, J., Mezzano, S. A., Ortíz, A., Egido, J., & Ruiz‐Ortega, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014145 · Cited by 65
Rodríguez-Peña, A. B., Prieto, M., Düwel, A., Rivas, J. V., Eleno, N., Pérez‐Barriocanal, F., Arévalo, M. A., Smith, J. D., Vary, C., Bernabéu, C., et al. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_1.34 · Cited by 56
Efstratiadis, G., Divani, M., Katsioulis, E., & Vergoulas, G. (2009) · PubMed Central · Cited by 56
Therapeutic strategies to halt renal fibrosis
Yu, L. H. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00144-3 · Cited by 49
Effect of pirfenidone against vanadate-induced kidney fibrosis in rats
Al-Bayati, M. A., Xie, Y., Mohr, F. C., Margolin, S. B., & Giri, S. N. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01213-3 · Cited by 48
Fibrosis causes progressive kidney failure
Cohen, E. P. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90221-x · Cited by 47
Diah, S., Zhang, G., Nagai, Y., Zhang, W., Liu, G., Kimura, S., Hamid, M. R. W. H. A., Tamiya, T., Nishiyama, A., & Hitomi, H. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.09.018 · Cited by 46
Nelson, P. J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg175 · Cited by 46
Adjuvant strategies for prevention of glomerulosclerosis
McCarty, M. F. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2004.11.048 · Cited by 40
Deletion of bradykinin B1 receptor reduces renal fibrosis
Wang, P. H. M., Cenedeze, M. A., Campanholle, G., Malheiros, D. M. A. C., Torres, H. A. M., Pesquero, J. B., Pacheco‐Silva, Á., & Câmara, N. O. S. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.10.018 · Cited by 40
Rossini, M., Naito, T., Yang, H., Freeman, M. L., Donnert, E., Ma, L. J., Dunn, S., Sharma, K., & Fogo, A. B. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp724 · Cited by 37
Aging and the disposition and toxicity of mercury in rats
Bridges, C. C., Joshee, L., & Zalups, R. K. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.02.006 · Cited by 33
Nielsen, F. T., Jensen, B. L., Hansen, P., Marcussen, N., & Bie, P. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-42 · Cited by 28
Farnesyl transferase inhibitors induce neuroprotection by inhibiting Ha‐Ras signalling pathway
Ruocco, A., Santillo, M., Cicale, M., Serù, R., Cuda, G., Anrather, J., Iadecola, C., Postiglione, A., Avvedimento, E. V., & Paternò, R. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05935.x · Cited by 24
Liu, W., Tang, N., & Zhang, Q. (2009) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.2009.02.017 · Cited by 16
Bing, P., Maode, L., Li, F., & he, S. T. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.07.015 · Cited by 15
Rodríguez-Peña, A. B., Calvo, I. F., Docherty, N. G., Arévalo, M. A., Grande, M. T., Eleno, N., Pérez‐Barriocanal, F., & López-Novoa, J. M. (2014) · BioMed Research International · doi:10.1155/2014/124902 · Cited by 15
Halofuginone reduces the occurrence of renal fibrosis in 5/6 nephrectomized rats.
Benchetrit, S., Yarkoni, S., Rathaus, M., Pines, M., Rashid, G., Bernheim, J., & Bernheim, J. (2007) · PubMed · Cited by 14
Cited by
Cellular and molecular mechanisms of kidney fibrosis
Djudjaj, S., & Boor, P. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.002 · Cited by 475
Chen, L., Yang, T., Lu, D.-W., Zhao, H., Feng, Y.-L., Chen, H., Chen, D.-Q., Vaziri, N. D., & Zhao, Y.-Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.090 · Cited by 359
Jun, J.-I., & Lau, L. F. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93563 · Cited by 345
Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin
Qin, L., Liu, N., Bao, C.-L.-M., Yang, D.-Z., Ma, G.-X., Yi, W.-H., Xiao, G.-Z., & Cao, H.-L. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00952-0 · Cited by 114
“Renal fibrosis Bradykinin B1 receptor deficient mice [301]; TGF-β- overexpressing rat [302]; Nep25 transgenic mice [303]; AT1 receptor-deficient mice [304]; Coll-GFP mice [305]; Drug induced models [306]: (HgCl2, Vanadate, Adriamycin, Uranyl nitrate, Folic acid etc.”
BackgroundHe, Z., Hu, Y., Niu, Z., Zhong, K., Liu, T., Yang, M., Ji, L., & Hu, W. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115865 · Cited by 93
Metadata
- Authors
- NOGUEIRA, A., PIRES, M. J., & OLIVEIRA, P. A.
- Venue
- In Vivo
- Published
- 2017-01-05
- Volume
- 31
- Issue
- 1
- Pages
- 1-22
- ISSN
- 0258-851X (ISSN-L)
- 1791-7549
- OpenAlex
- W2576066242
- Cited by
- 382
- References
- 75
- FWCI
- 26.52
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.